12-7485199-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_203416.4(CD163):c.2676T>C(p.Asn892Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00616 in 1,614,154 control chromosomes in the GnomAD database, including 244 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0053 ( 19 hom., cov: 32)
Exomes 𝑓: 0.0062 ( 225 hom. )
Consequence
CD163
NM_203416.4 synonymous
NM_203416.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.919
Genes affected
CD163 (HGNC:1631): (CD163 molecule) The protein encoded by this gene is a member of the scavenger receptor cysteine-rich (SRCR) superfamily, and is exclusively expressed in monocytes and macrophages. It functions as an acute phase-regulated receptor involved in the clearance and endocytosis of hemoglobin/haptoglobin complexes by macrophages, and may thereby protect tissues from free hemoglobin-mediated oxidative damage. This protein may also function as an innate immune sensor for bacteria and inducer of local inflammation. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 12-7485199-A-G is Benign according to our data. Variant chr12-7485199-A-G is described in ClinVar as [Benign]. Clinvar id is 779946.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.919 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.054 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00528 AC: 803AN: 152206Hom.: 19 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
803
AN:
152206
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00866 AC: 2175AN: 251162 AF XY: 0.00903 show subpopulations
GnomAD2 exomes
AF:
AC:
2175
AN:
251162
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00625 AC: 9131AN: 1461830Hom.: 225 Cov.: 33 AF XY: 0.00668 AC XY: 4855AN XY: 727226 show subpopulations
GnomAD4 exome
AF:
AC:
9131
AN:
1461830
Hom.:
Cov.:
33
AF XY:
AC XY:
4855
AN XY:
727226
Gnomad4 AFR exome
AF:
AC:
23
AN:
33480
Gnomad4 AMR exome
AF:
AC:
96
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
427
AN:
26134
Gnomad4 EAS exome
AF:
AC:
3472
AN:
39700
Gnomad4 SAS exome
AF:
AC:
1506
AN:
86256
Gnomad4 FIN exome
AF:
AC:
36
AN:
53420
Gnomad4 NFE exome
AF:
AC:
2871
AN:
1111954
Gnomad4 Remaining exome
AF:
AC:
606
AN:
60396
Heterozygous variant carriers
0
542
1085
1627
2170
2712
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00528 AC: 805AN: 152324Hom.: 19 Cov.: 32 AF XY: 0.00589 AC XY: 439AN XY: 74486 show subpopulations
GnomAD4 genome
AF:
AC:
805
AN:
152324
Hom.:
Cov.:
32
AF XY:
AC XY:
439
AN XY:
74486
Gnomad4 AFR
AF:
AC:
0.00125102
AN:
0.00125102
Gnomad4 AMR
AF:
AC:
0.00392003
AN:
0.00392003
Gnomad4 ASJ
AF:
AC:
0.0192972
AN:
0.0192972
Gnomad4 EAS
AF:
AC:
0.0594365
AN:
0.0594365
Gnomad4 SAS
AF:
AC:
0.0159619
AN:
0.0159619
Gnomad4 FIN
AF:
AC:
0.000376577
AN:
0.000376577
Gnomad4 NFE
AF:
AC:
0.00314558
AN:
0.00314558
Gnomad4 OTH
AF:
AC:
0.00993377
AN:
0.00993377
Heterozygous variant carriers
0
45
89
134
178
223
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
May 14, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at